Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion type Assertion NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_head.
- NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion description "[The distribution of VDR genotyping in patients with SLE was 1.9% for BB (non-excisable allele homozygote), 21.78% for Bb (heterozygote), and 76.23% for bb (excisable allele homozygote).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_provenance.
- NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion evidence source_evidence_literature NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_provenance.
- NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion SIO_000772 16507161 NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_provenance.
- NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion wasDerivedFrom befree-20140225 NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_provenance.
- NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_assertion wasGeneratedBy ECO_0000203 NP314234.RA7qjAhMYBLK3p2acQctiU5r269ceodlqx9o_gBao72j0130_provenance.